2021 Revenues ($USD) : $3,550,317,030
2021 Revenues (foreign currencies) : RMB22,902,385,100
2021 R&D spend : $146,028,400
2021 Number of Employees : 34,912
Fiscal Year End : 12/31/2021
Leader : CEO Ge Li

With operations across Asia, Europe, and North America, WuXi AppTec offers a broad range of R&D and manufacturing services to the global pharmaceutical and healthcare industries. WuXi AppTech’s revenues grew 38.5% in 2021. Nearly two-thirds of the sales came from the company’s WuXi Chemistry business, which saw a 46.9% revenue increase. The Shanghai-based company said in its 2021 annual results presentation that it expects WuXi Chemistry sales to nearly double in 2022. —CN